Enhertu, a targeted cancer therapy from partners AstraZeneca and Daiichi Sankyo, may now be used as a first-line treatment for advanced cases of breast cancer, making it the first new approved ...

The amount of noise The Row’s annual sample sale generated last weekend was perhaps antithetical to the brand’s ultimate quiet luxury status. But what else could be expected? The brand’s legions of ...

An EDN Design Idea (DI) presented a discussion of how to increase the resolution of an ADC by adding a non-deterministic, zero-mean, Gaussian noise dither waveform to a signal to be converted; then, ...

Capital includes assets like cash, machinery, and patents used to create value. Businesses acquire capital through equity, debt, or retaining earnings. Capital investment decisions are based on the ...

KILLEEN— After more than two decades in uniform, U.S. Army Master Sgt. Fabian Balarezo is living proof that personal growth doesn’t end with rank, and that education can be a bridge between military ...

It feels like, of all the roles in League of Legends, ADC is the most variable. Sometimes you're absolutely unstoppable, critting all over the place and one-shotting squishies, while simultaneously ...

Agree Realty has outperformed peers and the S&P 500 since our last update, driven by a strong dividend yield and share price recovery. Even with the greater volatility that the broader market has been ...

Roche has secured its third antibody-drug conjugate pact of the year, this time agreeing to hand $36 million in upfront payments to Oxford BioTherapeutics. The agreement will also see U.K.-based ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

ADCs have transformed aUC treatment but are associated with significant adverse events, particularly in sacituzumab govitecan-based regimens. Enfortumab vedotin, especially with pembrolizumab, shows ...

Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall readout is in line with the Chinese data that drummed up excitement in the ...

In the chemical world, the tiny hyphen in antibody-drug conjugates—or ADCs, as they’re commonly known—does a lot more work than the perfunctory punctuation suggests. That hyphen stands for the ...